Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy
出版年份 2021 全文链接
标题
Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy
作者
关键词
-
出版物
ENDOCRINE REVIEWS
Volume -, Issue -, Pages -
出版商
The Endocrine Society
发表日期
2021-10-26
DOI
10.1210/endrev/bnab034
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus
- (2021) Long Cheng et al. Adipocyte
- Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity
- (2021) Steven B. Heymsfield et al. JAMA Network Open
- The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling
- (2021) Qian Zhang et al. Cell Metabolism
- Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity
- (2021) Thomas A. Wadden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Leptin in Leanness and Obesity
- (2021) Nikolaos Perakakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
- (2021) Melanie Davies et al. LANCET
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- GFRAL-expressing neurons suppress food intake via aversive pathways
- (2021) Paul V. Sabatini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH
- (2021) Leigh Goedeke et al. Molecular Metabolism
- Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV
- (2021) Krzysztof Strojek et al. Diabetes Therapy
- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
- (2021) Domenica Rubino et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- AM833 is a novel agonist of calcitonin family G protein-coupled receptors: pharmacological comparison to six selective and non-selective agonists
- (2021) Madeleine M Fletcher et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
- (2021) Lone B Enebo et al. LANCET
- Addressing the epidemic of fatty liver disease: A call to action, a call to collaboration, a call to moving the field forward
- (2021) Chrysoula Boutari et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV
- (2021) Matthew J. Budoff et al. Diabetes Therapy
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bariatric and Metabolic Endoscopy: A New Paradigm
- (2021) Andrea Telese et al. Clinical and Translational Gastroenterology
- Dose‐dependent reduction in body weight with LIK066 treatment in Japanese patients with obesity
- (2020) Koutaro Yokote et al. DIABETES OBESITY & METABOLISM
- Gastrointestinal Peptides as Therapeutic Targets to Mitigate Obesity and Metabolic Syndrome
- (2020) Kleopatra Alexiadou et al. Current Diabetes Reports
- Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT ‐2 study): 52‐week results from a randomized controlled trial
- (2020) Chantal Mathieu et al. DIABETES OBESITY & METABOLISM
- The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans
- (2020) Brian S. Finlin et al. JOURNAL OF CLINICAL INVESTIGATION
- Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity
- (2020) Alana E. O’Mara et al. JOURNAL OF CLINICAL INVESTIGATION
- Might β3-adrenergic receptor agonists be useful in disorders of glucose homeostasis?
- (2020) Jeffrey S. Flier JOURNAL OF CLINICAL INVESTIGATION
- Combination gut hormones: prospects and questions for the future of obesity and diabetes therapy
- (2020) Bernard Khoo et al. JOURNAL OF ENDOCRINOLOGY
- Epigenetic contribution to obesity
- (2020) Meriem Ouni et al. MAMMALIAN GENOME
- Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus
- (2020) Steven B. Heymsfield et al. Obesity
- Methylphenidate improves weight control in childhood brain tumor survivors with hypothalamic obesity
- (2020) Vincent E. Horne et al. PEDIATRIC BLOOD & CANCER
- Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial
- (2020) Elaine W. Yu et al. PLOS MEDICINE
- Drug Therapy in Obesity: A Review of Current and Emerging Treatments
- (2020) David M. Williams et al. Diabetes Therapy
- Benefit:Risk Profile of Dapagliflozin 5 mg in the DEPICT ‐1 and ‐2 Trials in Individuals with Type 1 Diabetes and BMI ≥27 kg/m 2
- (2020) Chantal Mathieu et al. DIABETES OBESITY & METABOLISM
- Autologous fecal transplantation from a lean state potentiates caloric restriction effects on body weight and adiposity in obese mice
- (2020) Patricia Pérez-Matute et al. Scientific Reports
- The Implication of Gut Hormones in the Regulation of Energy Homeostasis and Their Role in the Pathophysiology of Obesity
- (2020) Chrysi Koliaki et al. Current Obesity Reports
- Nanoparticle-Mediated Inhibition of Notch Signaling Promotes Mitochondrial Biogenesis and Reduces Subcutaneous Adipose Tissue Expansion in Pigs
- (2020) Di Huang et al. iScience
- Induction of Adipose Tissue Browning as a Strategy to Combat Obesity
- (2020) Alina Kuryłowicz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer Risk Associated with Lorcaserin — The FDA’s Review of the CAMELLIA-TIMI 61 Trial
- (2020) John Sharretts et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intensive Weight Loss Intervention and Cancer Risk in Adults with Type 2 Diabetes: Analysis of the Look AHEAD Randomized Clinical Trial
- (2020) et al. Obesity
- Leptin alters energy intake and fat mass but not energy expenditure in lean subjects
- (2020) Pavlina Chrysafi et al. Nature Communications
- Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis
- (2020) Yoon Ji Kim et al. Frontiers in Endocrinology
- Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52‐week outcomes from the DEPICT ‐1 and ‐2 studies
- (2020) Moshe Phillip et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of adding sotagliflozin, a dual sodium‐glucose co‐transporter ( SGLT)1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline body mass index ≥ 27 kg/m 2
- (2020) Thomas Danne et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
- (2020) Karine Clément et al. Lancet Diabetes & Endocrinology
- GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice
- (2019) Henriette Frikke-Schmidt et al. Molecular Metabolism
- The Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesity
- (2019) Tomás Cerdó et al. Nutrients
- Probiotics: How Effective Are They in the Fight against Obesity?
- (2019) Kiran Mazloom et al. Nutrients
- Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3‐month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long‐term Use study
- (2019) Kazuyuki Tobe et al. Journal of Diabetes Investigation
- Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study
- (2019) Natasha C. Bergmann et al. DIABETOLOGIA
- The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes
- (2019) Yan‐Ling He et al. DIABETES OBESITY & METABOLISM
- A Long-Acting PYY3–36 Analog Mediates Robust Anorectic Efficacy with Minimal Emesis in Nonhuman Primates
- (2019) Shamina M. Rangwala et al. Cell Metabolism
- Effect of bariatric surgery on plasma GDF15 in humans
- (2019) Maximilian Kleinert et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Epigenetics in Human Obesity and Type 2 Diabetes
- (2019) Charlotte Ling et al. Cell Metabolism
- Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
- (2019) Alison B. Evert et al. DIABETES CARE
- Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes
- (2019) Brian Finan et al. DIABETES
- PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes
- (2019) Vanita R. Aroda et al. DIABETES CARE
- Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study
- (2019) Preeshila Behary et al. DIABETES CARE
- Sotagliflozin: First Global Approval
- (2019) Anthony Markham et al. DRUGS
- Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial
- (2019) Richard Pratley et al. LANCET
- Of mice and men: incretin actions in the central nervous system
- (2019) Olivia M. Farr et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Combined Amylin/GLP-1 pharmacotherapy to promote and sustain long-lasting weight loss
- (2019) Claudia G. Liberini et al. Scientific Reports
- Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
- (2019) Thomas R Pieber et al. Lancet Diabetes & Endocrinology
- Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
- (2019) Helena W. Rodbard et al. DIABETES CARE
- Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance
- (2019) Jee Young Chung et al. GENOME RESEARCH
- CNS-targeting pharmacological interventions for the metabolic syndrome
- (2019) Kerstin Stemmer et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects from diet-induced gut microbiota dysbiosis and obesity can be ameliorated by fecal microbiota transplantation: A multiomics approach
- (2019) Maria Guirro et al. PLoS One
- Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial
- (2019) Eiichi Araki et al. DIABETES OBESITY & METABOLISM
- Efficacy, safety, and mechanistic insights of cotadutide a dual receptor glucagon-like peptide-1 and glucagon agonist
- (2019) Victoria E R Parker et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New insights into the secretory functions of brown adipose tissue
- (2019) Joan Villarroya et al. JOURNAL OF ENDOCRINOLOGY
- Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?
- (2019) Alexander Kokkinos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates
- (2019) Leigh Goedeke et al. Science Translational Medicine
- Dynamic changes of muscle insulin sensitivity after metabolic surgery
- (2019) Sofiya Gancheva et al. Nature Communications
- Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome—A Systematic Review
- (2019) Zhang et al. Nutrients
- Methylphenidate in children with monogenic obesity due to LEPR or MC4R deficiency improves feeling of satiety and reduces BMI‐SDS—A case series
- (2019) Stephanie Brandt et al. Pediatric Obesity
- Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet
- (2019) Liang Xu et al. BMJ Open Diabetes Research & Care
- Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: Evidence from two independent trials
- (2019) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Polymeric Carriers for Controlled Drug Delivery in Obesity Treatment
- (2019) Di Huang et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Important Considerations for the Treatment of Patients with Diabetes Mellitus and Heart Failure from a Diabetologist’s Perspective: Lessons Learned from Cardiovascular Outcome Trials
- (2019) Chrysi Koliaki et al. International Journal of Environmental Research and Public Health
- Nanotechnology advances towards development of targeted-treatment for obesity
- (2019) Nicole Remaliah Samantha Sibuyi et al. JOURNAL OF NANOBIOTECHNOLOGY
- A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice
- (2018) David C. Hornigold et al. APPETITE
- Advances in Biomaterials for Drug Delivery
- (2018) Owen S. Fenton et al. ADVANCED MATERIALS
- Human brown adipose tissue: Underestimated target in metabolic disease?
- (2018) Michiel P.B. Moonen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Mirabegron: potential off target effects and uses beyond the bladder
- (2018) Nodi Dehvari et al. BRITISH JOURNAL OF PHARMACOLOGY
- Efficacy of Metreleptin for Weight Loss in Overweight and Obese Adults with Low Leptin Levels
- (2018) ALEX DEPAOLI et al. DIABETES
- Effects of the Novel Dual GLP-1R/GCGR Agonist SAR425899 on Postprandial Glucose Metabolism in Overweight/Obese Subjects with Type 2 Diabetes
- (2018) BRITTA GOEBEL et al. DIABETES
- Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
- (2018) John B. Buse et al. DIABETES CARE
- HbA1cand Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
- (2018) Thomas Danne et al. DIABETES CARE
- Antisense Inhibition of Protein Tyrosine Phosphatase 1B With IONIS-PTP-1B Rx Improves Insulin Sensitivity and Reduces Weight in Overweight Patients With Type 2 Diabetes
- (2018) Andres Digenio et al. DIABETES CARE
- Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION-8 study
- (2018) Serge A. Jabbour et al. DIABETES OBESITY & METABOLISM
- Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial
- (2018) Richard E. Pratley et al. DIABETES OBESITY & METABOLISM
- Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
- (2018) Bo Ahrén et al. DIABETES OBESITY & METABOLISM
- The Science of Obesity Management: An Endocrine Society Scientific Statement
- (2018) George A Bray et al. ENDOCRINE REVIEWS
- A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide
- (2018) Tine A. Bækdal et al. Expert Opinion on Drug Metabolism & Toxicology
- Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lactobacillus gasseri BNR17 Supplementation Reduces the Visceral Fat Accumulation and Waist Circumference in Obese Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2018) Joohee Kim et al. JOURNAL OF MEDICINAL FOOD
- Obesity
- (2018) Kishore M. Gadde et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
- (2018) Philip Ambery et al. LANCET
- [D-Leu-4]-OB3 and MA-[D-Leu-4]-OB3, small molecule synthetic peptide leptin mimetics, improve glycemic control in diet-induced obese (DIO) mice
- (2018) Anke Wang et al. PEPTIDES
- Gut hormone polyagonists for the treatment of type 2 diabetes
- (2018) Sara J. Brandt et al. PEPTIDES
- The Common and Distinct Features of Brown and Beige Adipocytes
- (2018) Kenji Ikeda et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond
- (2018) Shannon E. Mullican et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Sodium-glucose cotransporter 2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus) Study
- (2018) Takashi Sasaki et al. Journal of Diabetes Investigation
- Exercise, Obesity and CNS Control of Metabolic Homeostasis: A Review
- (2018) John K. Smith Frontiers in Physiology
- Amylin – Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity
- (2018) Christina Neuner Boyle et al. Molecular Metabolism
- A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo-controlled first-in-human and first-in-patient trials
- (2018) Joachim Tillner et al. DIABETES OBESITY & METABOLISM
- Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients with Prediabetes
- (2018) Alejandra Ramírez-Rodríguez et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues
- (2018) Christopher Lipina et al. FASEB JOURNAL
- Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry
- (2018) Loic Yengo et al. HUMAN MOLECULAR GENETICS
- Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial
- (2018) Anna Pedret et al. INTERNATIONAL JOURNAL OF OBESITY
- Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
- (2018) Patrick M O'Neil et al. LANCET
- Secretin-Activated Brown Fat Mediates Prandial Thermogenesis to Induce Satiation
- (2018) Yongguo Li et al. CELL
- Effect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus: An open-label, prospective, randomized, parallel-group comparison
- (2018) Kyu Yong Cho et al. DIABETES OBESITY & METABOLISM
- Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmö Diet and Cancer–Cardiovascular Cohort
- (2018) Xue Bao et al. DIABETOLOGIA
- Starvation in the Midst of Plenty: Reflections on the History and Biology of Insulin and Leptin
- (2018) Jeffrey S Flier ENDOCRINE REVIEWS
- Vascular targeted nanotherapeutic approach for obesity treatment
- (2018) Nicole Sibuyi et al. International Journal of Nanomedicine
- Impact of overweight, obesity and severe obesity on life expectancy of Australian adults
- (2018) Thomas Lung et al. INTERNATIONAL JOURNAL OF OBESITY
- Methylphenidate and Reduced Overweight in Children With ADHD
- (2018) Elisabeth Mellström et al. Journal of Attention Disorders
- Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
- (2018) Juan Pablo Frias et al. LANCET
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pharmacotherapy of obesity: Available medications and drugs under investigation
- (2018) Eleni Pilitsi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding
- (2018) Paul E. O’Brien et al. OBESITY SURGERY
- CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency
- (2018) Navneet Matharu et al. SCIENCE
- Is It Time to Use Probiotics to Prevent or Treat Obesity?
- (2018) Andrea Brusaferro et al. Nutrients
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
- (2018) Tamer Coskun et al. Molecular Metabolism
- Obesity Pathogenesis: An Endocrine Society Scientific Statement
- (2017) Michael W Schwartz et al. ENDOCRINE REVIEWS
- The Importance of the Gastrointestinal Tract in Controlling Food Intake and Regulating Energy Balance
- (2017) Mariana P. Monteiro et al. GASTROENTEROLOGY
- Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity
- (2017) Alissa C. Nicolucci et al. GASTROENTEROLOGY
- The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers
- (2017) Tricia Tan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Intranasal delivery of N-terminal modified leptin-pluronic conjugate for treatment of obesity
- (2017) Dongfen Yuan et al. JOURNAL OF CONTROLLED RELEASE
- GPR55: a new promising target for metabolism?
- (2017) Eva Tudurí et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesity
- (2017) Livia B. Pascoal et al. Journal of Neuroinflammation
- GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice
- (2017) Søren B. van Witteloostuijn et al. JOURNAL OF PEPTIDE SCIENCE
- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
- (2017) Carel W le Roux et al. LANCET
- Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay
- (2017) M R Lee et al. MOLECULAR PSYCHIATRY
- Dibenzazepine-Loaded Nanoparticles Induce Local Browning of White Adipose Tissue to Counteract Obesity
- (2017) Chunhui Jiang et al. MOLECULAR THERAPY
- Nanogel-based nasal ghrelin vaccine prevents obesity
- (2017) T Azegami et al. Mucosal Immunology
- Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15
- (2017) Jer-Yuan Hsu et al. NATURE
- GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
- (2017) Linda Yang et al. NATURE MEDICINE
- GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
- (2017) Shannon E Mullican et al. NATURE MEDICINE
- The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL
- (2017) Paul J Emmerson et al. NATURE MEDICINE
- Current pharmacotherapy for obesity
- (2017) Gitanjali Srivastava et al. Nature Reviews Endocrinology
- The effects of oxytocin on eating behaviour and metabolism in humans
- (2017) Elizabeth A. Lawson Nature Reviews Endocrinology
- Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
- (2017) Satish K. Garg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Role of microRNAs on adipogenesis, chronic low-grade inflammation, and insulin resistance in obesity
- (2017) Kyria Jayanne Clímaco Cruz et al. NUTRITION
- The Association Between the Dosage of SGLT2 Inhibitor and Weight Reduction in Type 2 Diabetes Patients: A Meta-Analysis
- (2017) Xiaoling Cai et al. Obesity
- Ghrelin, CCK, GLP-1, and PYY(3–36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB
- (2017) Robert E. Steinert et al. PHYSIOLOGICAL REVIEWS
- Gut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation
- (2017) Jana Pindjakova et al. Frontiers in Microbiology
- Effect of bimagrumab on thigh muscle volume and composition in men with casting-induced atrophy
- (2017) Daniel S. Rooks et al. Journal of Cachexia Sarcopenia and Muscle
- Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
- (2017) Christopher Sorli et al. Lancet Diabetes & Endocrinology
- Targeted Hyaluronate–Hollow Gold Nanosphere Conjugate for Anti-Obesity Photothermal Lipolysis
- (2017) Jung Ho Lee et al. ACS Biomaterials-Science & Engineering
- Endospanin1 affects oppositely body weight regulation and glucose homeostasis by differentially regulating central leptin signaling
- (2017) Virginie Vauthier et al. Molecular Metabolism
- Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency
- (2017) Tinh-Hai Collet et al. Molecular Metabolism
- Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
- (2017) Sigrid Jall et al. Molecular Metabolism
- Targeted Hyaluronate–Hollow Gold Nanosphere Conjugate for Anti-Obesity Photothermal Lipolysis
- (2017) Jung Ho Lee et al. ACS Biomaterials Science & Engineering
- SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
- (2017) Liang Xu et al. EBioMedicine
- Intranasal Oxytocin: Myths and Delusions
- (2016) Gareth Leng et al. BIOLOGICAL PSYCHIATRY
- Unimolecular Polypharmacy for Treatment of Diabetes and Obesity
- (2016) Matthias H. Tschöp et al. Cell Metabolism
- Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III Trials
- (2016) Soichi Sakai et al. CLINICAL THERAPEUTICS
- Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates
- (2016) S. J. Henderson et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of triple therapy with dapagliflozin add-on to saxagliptin plus metformin over 52 weeks in patients with type 2 diabetes
- (2016) C. Mathieu et al. DIABETES OBESITY & METABOLISM
- GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans
- (2016) Bo Liu et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis
- (2016) F. Zaccardi et al. DIABETES OBESITY & METABOLISM
- Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes
- (2016) Per Lundkvist et al. DIABETES OBESITY & METABOLISM
- Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice
- (2016) Aine M. McKillop et al. DIABETOLOGIA
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY
- (2016) W. Timothy Garvey et al. Endocrine Practice
- Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial
- (2016) F Higashikawa et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus
- (2016) Panai Song et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- GPR119: a promising target for nonalcoholic fatty liver disease
- (2016) Jin Won Yang et al. FASEB JOURNAL
- Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events
- (2016) Rohan Khera et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- World Gastroenterology Organisation Global Guidelines Irritable Bowel Syndrome
- (2016) Eamonn M.M. Quigley et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- RNAi-mediated silencing of TNF-α converting enzyme to down-regulate soluble TNF-α production for treatment of acute and chronic colitis
- (2016) Yoonsung Song et al. JOURNAL OF CONTROLLED RELEASE
- Central nervous system regulation of eating: Insights from human brain imaging
- (2016) Olivia M. Farr et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Convertible visceral fat as a therapeutic target to curb obesity
- (2016) Antonio Giordano et al. NATURE REVIEWS DRUG DISCOVERY
- Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
- (2016) Peter Kühnen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Probiotics in prevention and treatment of obesity: a critical view
- (2016) Nazarii Kobyliak et al. Nutrition & Metabolism
- The additional effects of a probiotic mix on abdominal adiposity and antioxidant Status: A double-blind, randomized trial
- (2016) Aline Corado Gomes et al. Obesity
- Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations
- (2016) Francesco Rubino et al. OBESITY SURGERY
- Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles
- (2016) Yuan Xue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reappraisal of GIP Pharmacology for Metabolic Diseases
- (2016) Brian Finan et al. TRENDS IN MOLECULAR MEDICINE
- Bariatric Surgery and Long-term Durability of Weight Loss
- (2016) Matthew L. Maciejewski et al. JAMA Surgery
- Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults—Randomized Controlled Trial
- (2016) Lotta K. Stenman et al. EBioMedicine
- Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study
- (2016) Markus Scheerer et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Sustained Treatment with Insulin Detemir in Mice Alters Brain Activity and Locomotion
- (2016) Tina Sartorius et al. PLoS One
- Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation
- (2016) Mikael Bjursell et al. PLoS One
- Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys
- (2015) James E. Blevins et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Cardiovascular Safety Pharmacology of Sibutramine
- (2015) Jaesuk Yun et al. Biomolecules & Therapeutics
- Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation
- (2015) Valentina Tremaroli et al. Cell Metabolism
- Activation of Human Brown Adipose Tissue by a β3-Adrenergic Receptor Agonist
- (2015) Aaron M. Cypess et al. Cell Metabolism
- Brown and Beige Fat: Physiological Roles beyond Heat Generation
- (2015) Shingo Kajimura et al. Cell Metabolism
- GLP-1 and Amylin in the Treatment of Obesity
- (2015) T. Jorsal et al. Current Diabetes Reports
- Adeno-associated virus serotypes for gene therapeutics
- (2015) Leszek Lisowski et al. CURRENT OPINION IN PHARMACOLOGY
- Effects of Intranasal Insulin on Hepatic Fat Accumulation and Energy Metabolism in Humans
- (2015) Sofiya Gancheva et al. DIABETES
- A Novel CCK-8/GLP-1 Hybrid Peptide Exhibiting Prominent Insulinotropic, Glucose-Lowering, and Satiety Actions With Significant Therapeutic Potential in High-Fat–Fed Mice
- (2015) Nigel Irwin et al. DIABETES
- Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
- (2015) Arthur T. Sands et al. DIABETES CARE
- Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition
- (2015) Giulia Ferrannini et al. DIABETES CARE
- Weight-sparing effect of insulin detemir: a consequence of central nervous system-mediated reduced energy intake?
- (2015) D. Russell-Jones et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes
- (2015) G. Fulcher et al. DIABETES OBESITY & METABOLISM
- Empagliflozin as add-on to metformin in people with Type 2 diabetes
- (2015) L. Merker et al. DIABETIC MEDICINE
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity
- (2015) A Meadows et al. INTERNATIONAL JOURNAL OF OBESITY
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- RM-493, a Melanocortin-4 Receptor (MC4R) Agonist, Increases Resting Energy Expenditure in Obese Individuals
- (2015) Kong Y. Chen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Role of apoptosis and necrosis in cell death induced by nanoparticle-mediated photothermal therapy
- (2015) Varun P. Pattani et al. JOURNAL OF NANOPARTICLE RESEARCH
- Targeted delivery using peptide-functionalised gold nanoparticles to white adipose tissues of obese rats
- (2015) Ntevheleni Thovhogi et al. JOURNAL OF NANOPARTICLE RESEARCH
- From leptin to other adipokines in health and disease: Facts and expectations at the beginning of the 21st century
- (2015) Matthias Blüher et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Therapeutic genome editing: prospects and challenges
- (2015) David Benjamin Turitz Cox et al. NATURE MEDICINE
- Hypothalamic innate immune reaction in obesity
- (2015) Stefanie Kälin et al. Nature Reviews Endocrinology
- Enteroendocrine cells: a review of their role in brain-gut communication
- (2015) R. Latorre et al. NEUROGASTROENTEROLOGY AND MOTILITY
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- European Guidelines for Obesity Management in Adults
- (2015) Volkan Yumuk et al. Obesity Facts
- Translational and therapeutic potential of oxytocin as an anti-obesity strategy: Insights from rodents, nonhuman primates and humans
- (2015) James E. Blevins et al. PHYSIOLOGY & BEHAVIOR
- Correction: Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages
- (2015) Mirko Lanuti et al. PLoS One
- Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist
- (2015) Sherrica Tai et al. PSYCHOPHARMACOLOGY
- Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
- (2015) R. J. Perry et al. SCIENCE
- Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders
- (2015) Jun Zhang et al. Frontiers in Endocrinology
- Activation of GPR18 by cannabinoid compounds: a tale of biased agonism
- (2014) Linda Console-Bram et al. BRITISH JOURNAL OF PHARMACOLOGY
- What We Talk About When We Talk About Fat
- (2014) Evan D. Rosen et al. CELL
- Dapagliflozin as Monotherapy in Drug-Naive Asian Patients With Type 2 Diabetes Mellitus: A Randomized, Blinded, Prospective Phase III Study
- (2014) Linong Ji et al. CLINICAL THERAPEUTICS
- Bile acids and the gut microbiome
- (2014) Jason M. Ridlon et al. CURRENT OPINION IN GASTROENTEROLOGY
- Coinfusion of Low-Dose GLP-1 and Glucagon in Man Results in a Reduction in Food Intake
- (2014) Jaimini Cegla et al. DIABETES
- Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes
- (2014) Bruce Neal et al. DIABETES CARE
- Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial
- (2014) Hans-Ulrich Häring et al. DIABETES CARE
- Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes
- (2014) Julio Rosenstock et al. DIABETES CARE
- Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise
- (2014) K. Kaku et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double-blind placebo-controlled 102-week trial
- (2014) C. J. Bailey et al. DIABETIC MEDICINE
- SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats
- (2014) Masanori Yokono et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism
- (2014) K Chrysovergis et al. INTERNATIONAL JOURNAL OF OBESITY
- Modeling, Molecular Dynamics Simulation, and Mutation Validation for Structure of Cannabinoid Receptor 2 Based on Known Crystal Structures of GPCRs
- (2014) Zhiwei Feng et al. Journal of Chemical Information and Modeling
- Decreased Circulating Levels of Oxytocin in Obesity and Newly Diagnosed Type 2 Diabetic Patients
- (2014) Weiyun Qian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
- (2014) Ele Ferrannini et al. JOURNAL OF CLINICAL INVESTIGATION
- Comparative assessments of crucial factors for a functional ligand-targeted nanocarrier
- (2014) Md. Nazir Hossen et al. JOURNAL OF DRUG TARGETING
- Therapeutic Protein–Polymer Conjugates: Advancing Beyond PEGylation
- (2014) Emma M. Pelegri-O’Day et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Inhibition of Notch signaling promotes browning of white adipose tissue and ameliorates obesity
- (2014) Pengpeng Bi et al. NATURE MEDICINE
- A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
- (2014) Brian Finan et al. NATURE MEDICINE
- Treatment of sporadic inclusion body myositis with bimagrumab
- (2014) A. A. Amato et al. NEUROLOGY
- Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss
- (2014) Sonja K. Billes et al. PHARMACOLOGICAL RESEARCH
- Adipocyte dysfunction, inflammation and metabolic syndrome
- (2014) Nora Klöting et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial
- (2014) Martin Ridderstråle et al. Lancet Diabetes & Endocrinology
- AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
- (2014) R. Jude Samulski et al. Annual Review of Virology
- Adipokines – removing road blocks to obesity and diabetes therapy
- (2014) Matthias Blüher Molecular Metabolism
- Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial
- (2014) Krzysztof Strojek et al. Diabetes Therapy
- Long-Term Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Receiving High Doses of Insulin
- (2013) John P.H. Wilding ANNALS OF INTERNAL MEDICINE
- A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activity
- (2013) Elisabetta Bianchi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
- (2013) Clifford J Bailey et al. BMC Medicine
- Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials
- (2013) Nicole J. Kellow et al. BRITISH JOURNAL OF NUTRITION
- Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice
- (2013) A M McKillop et al. BRITISH JOURNAL OF PHARMACOLOGY
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
- (2013) Lei S. Qi et al. CELL
- Reversal of Hypertriglyceridemia, Fatty Liver Disease, and Insulin Resistance by a Liver-Targeted Mitochondrial Uncoupler
- (2013) Rachel J. Perry et al. Cell Metabolism
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
- (2013) Gregory Gaich et al. Cell Metabolism
- Integration of Satiety Signals by the Central Nervous System
- (2013) Adam P. Chambers et al. CURRENT BIOLOGY
- Immunization Against Active Ghrelin Using Virus-Like Particles for Obesity Treatment
- (2013) Sara Andrade et al. CURRENT PHARMACEUTICAL DESIGN
- The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1
- (2013) Klaus Unsicker et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Anatomical Locations of Human Brown Adipose Tissue: Functional Relevance and Implications in Obesity and Type 2 Diabetes
- (2013) H. Sacks et al. DIABETES
- Long-Term Safety and Efficacy of Empagliflozin, Sitagliptin, and Metformin: An active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes
- (2013) E. Ferrannini et al. DIABETES CARE
- Dapagliflozin Is Effective as Add-on Therapy to Sitagliptin With or Without Metformin: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Serge A. Jabbour et al. DIABETES CARE
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial
- (2013) C. S. Kovacs et al. DIABETES OBESITY & METABOLISM
- Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
- (2013) H. J. Lambers Heerspink et al. DIABETES OBESITY & METABOLISM
- Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years
- (2013) J. P. H. Wilding et al. DIABETES OBESITY & METABOLISM
- Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
- (2013) J. Bolinder et al. DIABETES OBESITY & METABOLISM
- A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice
- (2013) V. K. Bhat et al. DIABETOLOGIA
- Are Bile Acids the New Gut Hormones? Lessons From Weight Loss Surgery Models
- (2013) D. J. Pournaras et al. ENDOCRINOLOGY
- A Surgical Model in Male Obese Rats Uncovers Protective Effects of Bile Acids Post-Bariatric Surgery
- (2013) Rohit Kohli et al. ENDOCRINOLOGY
- Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized-controlled clinical trial
- (2013) Parvin Dehghan et al. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
- Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
- (2013) T A Wadden et al. INTERNATIONAL JOURNAL OF OBESITY
- A Novel Glucagon-like Peptide-1 (GLP-1)/Glucagon Hybrid Peptide with Triple-acting Agonist Activity at Glucose-dependent Insulinotropic Polypeptide, GLP-1, and Glucagon Receptors and Therapeutic Potential in High Fat-fed Mice
- (2013) Victor A. Gault et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bifunctional PEGylated Exenatide-Amylinomimetic Hybrids to Treat Metabolic Disorders: An Example of Long-Acting Dual Hormonal Therapeutics
- (2013) Chengzao Sun et al. JOURNAL OF MEDICINAL CHEMISTRY
- Expression of concern—Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
- (2013) The Lancet Editors LANCET
- Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats
- (2013) Ikram Merroun et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Dietary intervention impact on gut microbial gene richness
- (2013) Aurélie Cotillard et al. NATURE
- Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity
- (2013) Eleanor Wheeler et al. NATURE GENETICS
- CRISPR RNA–guided activation of endogenous human genes
- (2013) Morgan L Maeder et al. NATURE METHODS
- CRISPR interference (CRISPRi) for sequence-specific control of gene expression
- (2013) Matthew H Larson et al. Nature Protocols
- Anti-hypertensive treatment preserves appetite suppression while preventing cardiovascular adverse effects of tesofensine in rats
- (2013) Bo Hjorth Bentzen et al. Obesity
- Randomized double-blind placebo-controlled study of leptin administration after gastric bypass
- (2013) Judith Korner et al. Obesity
- Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus
- (2013) Harold E. Bays et al. Obesity
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Role of oxytocin in energy metabolism
- (2013) Valéria Ernestânia Chaves et al. PEPTIDES
- Tesofensine induces appetite suppression and weight loss with reversal of low forebrain dopamine levels in the diet-induced obese rat
- (2013) Henrik H. Hansen et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Treatment of Obesity and Diabetes Using Oxytocin or Analogs in Patients and Mouse Models
- (2013) Hai Zhang et al. PLoS One
- Improved Glucose Control and Reduced Body Weight in Rodents with Dual Mechanism of Action Peptide Hybrids
- (2013) James L. Trevaskis et al. PLoS One
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- The endocannabinoid signaling system in cancer
- (2013) Simona Pisanti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice
- (2013) Katrin Rössger et al. Nature Communications
- Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans
- (2013) Nadine Striepens et al. Scientific Reports
- In Vivo Efficacy of HD0471953: A Novel GPR119 Agonist for the Treatment of Type 2 Diabetes Mellitus
- (2013) So Ra Kim et al. Journal of Diabetes Research
- Action and therapeutic potential of oxyntomodulin
- (2013) Alessandro Pocai Molecular Metabolism
- Inconsistencies in the assessment of food intake
- (2012) Stephen C. Woods et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- N -arachidonoyl glycine induces macrophage apoptosis via GPR18
- (2012) Rina Takenouchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dynamic and distinct histone modifications modulate the expression of key adipogenesis regulatory genes
- (2012) Qiongyi Zhang et al. CELL CYCLE
- Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
- (2012) Joseph Tam et al. Cell Metabolism
- Sibutramine Effects on Central Mechanisms Regulating Energy Homeostasis
- (2012) Joao R. Araujo et al. Current Neuropharmacology
- Chronic Treatment With a Melanocortin-4 Receptor Agonist Causes Weight Loss, Reduces Insulin Resistance, and Improves Cardiovascular Function in Diet-Induced Obese Rhesus Macaques
- (2012) P. Kievit et al. DIABETES
- Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia
- (2012) T. M. Tan et al. DIABETES
- Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes
- (2012) J. Rosenstock et al. DIABETES CARE
- Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy
- (2012) J. Rosenstock et al. DIABETES CARE
- Effects of JNJ-38431055, a novel GPR119 receptor agonist, in randomized, double-blind, placebo-controlled studies in subjects with type 2 diabetes
- (2012) L. B. Katz et al. DIABETES OBESITY & METABOLISM
- Dapagliflozin monotherapy in drug-naïve patients with diabetes: a randomized-controlled trial of low-dose range
- (2012) C. J. Bailey et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
- (2012) K. Stenlöf et al. DIABETES OBESITY & METABOLISM
- The Cannabinoid Receptor CB1 Modulates the Signaling Properties of the Lysophosphatidylinositol Receptor GPR55
- (2012) Julia Kargl et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
- (2012) Jan Bolinder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vascular-targeted nanotherapy for obesity: Unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery
- (2012) Md. Nazir Hossen et al. JOURNAL OF CONTROLLED RELEASE
- Blockade of the Activin Receptor IIB Activates Functional Brown Adipogenesis and Thermogenesis by Inducing Mitochondrial Oxidative Metabolism
- (2012) B. Fournier et al. MOLECULAR AND CELLULAR BIOLOGY
- The gut microbiota, obesity and insulin resistance
- (2012) Jian Shen et al. MOLECULAR ASPECTS OF MEDICINE
- Central nervous system control of metabolism
- (2012) Martin G. Myers et al. NATURE
- MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship
- (2012) Amy E. Pasquinelli NATURE REVIEWS GENETICS
- Anti-Inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in Mice
- (2012) Kun Li et al. PANCREAS
- Therapeutic modulation of intestinal dysbiosis
- (2012) Alan W. Walker et al. PHARMACOLOGICAL RESEARCH
- Macrophage Inhibitory Cytokine 1 (MIC-1/GDF15) Decreases Food Intake, Body Weight and Improves Glucose Tolerance in Mice on Normal & Obesogenic Diets
- (2012) Laurence Macia et al. PLoS One
- Effects of novel vaccines on weight loss in diet-induced-obese (DIO) mice
- (2012) Keith N Haffer Journal of Animal Science and Biotechnology
- Arcuate AgRP neurons and the regulation of energy balance
- (2012) Céline Cansell et al. Frontiers in Endocrinology
- Brown adipose tissue
- (2012) Kristy Townsend et al. Adipocyte
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin treatment
- (2011) Guo Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Implications of nonshivering thermogenesis for energy balance regulation in humans
- (2011) Wouter D. van Marken Lichtenbelt et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials
- (2011) Giovanni Musso et al. ANNALS OF MEDICINE
- Metagenomics and Personalized Medicine
- (2011) Herbert W. Virgin et al. CELL
- The Gut Hormones PYY3-36 and GLP-17-36 amide Reduce Food Intake and Modulate Brain Activity in Appetite Centers in Humans
- (2011) Akila De Silva et al. Cell Metabolism
- GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils
- (2011) Nariman A B Balenga et al. CELL RESEARCH
- Recombinant Human Leptin Treatment Does Not Improve Insulin Action in Obese Subjects With Type 2 Diabetes
- (2011) B. Mittendorfer et al. DIABETES
- Na+-D-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose Absorption and Glucose-Dependent Incretin Secretion
- (2011) V. Gorboulev et al. DIABETES
- Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice
- (2011) Amandine Everard et al. DIABETES
- The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats
- (2011) A. Díaz-Arteaga et al. DIABETES OBESITY & METABOLISM
- Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial
- (2011) K. Strojek et al. DIABETES OBESITY & METABOLISM
- Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
- (2011) R. Grempler et al. DIABETES OBESITY & METABOLISM
- Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
- (2011) A Astrup et al. INTERNATIONAL JOURNAL OF OBESITY
- Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids
- (2011) Sharon Anavi-Goffer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
- (2011) Silvana Y Romero-Zerbo et al. JOURNAL OF ENDOCRINOLOGY
- A role for central nervous system PPAR-γ in the regulation of energy balance
- (2011) Karen K Ryan et al. NATURE MEDICINE
- The Effect of Tesofensine on Appetite Sensations
- (2011) Jo-Anne Gilbert et al. Obesity
- Brown Adipose Tissue in Morbidly Obese Subjects
- (2011) Guy H. E. J. Vijgen et al. PLoS One
- Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders
- (2011) Stefan Lehr et al. Proteomics Clinical Applications
- Effects of Methylphenidate on Weight Gain and Food Intake in Hypothalamic Obesity
- (2011) Clinton Thomas Elfers et al. Frontiers in Endocrinology
- Aspectos cronobiológicos de la obesidad y el síndrome metabólico
- (2011) Purificación Gómez-Abellán et al. Endocrinologia y Nutricion
- The hypothalamic median eminence and its role in reproductive aging
- (2010) Weiling Yin et al. Annals of the New York Academy of Sciences
- N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor
- (2010) Douglas McHugh et al. BMC NEUROSCIENCE
- Prebiotic effects: metabolic and health benefits
- (2010) Marcel Roberfroid et al. BRITISH JOURNAL OF NUTRITION
- GPR55 ligands promote receptor coupling to multiple signalling pathways
- (2010) Christopher M Henstridge et al. BRITISH JOURNAL OF PHARMACOLOGY
- Transcriptional Control of Brown Fat Development
- (2010) Shingo Kajimura et al. Cell Metabolism
- The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients
- (2010) G. Vila et al. CLINICAL CHEMISTRY
- Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women
- (2010) Marleen Kars et al. DIABETES
- Euglycemic Infusion of Insulin Detemir Compared With Human Insulin Appears to Increase Direct Current Brain Potential Response and Reduces Food Intake While Inducing Similar Systemic Effects
- (2010) M. Hallschmid et al. DIABETES
- Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise: A randomized, double-blind, placebo-controlled, phase 3 trial
- (2010) E. Ferrannini et al. DIABETES CARE
- The effect of the triple monoamine reuptake inhibitor tesofensine on energy metabolism and appetite in overweight and moderately obese men
- (2010) A Sjödin et al. INTERNATIONAL JOURNAL OF OBESITY
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
- (2010) Joseph Tam et al. JOURNAL OF CLINICAL INVESTIGATION
- Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials
- (2010) M. A. Karsdal et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
- (2010) Clifford J Bailey et al. LANCET
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Behavioral and pharmacologic therapies for obesity
- (2010) Marion L. Vetter et al. Nature Reviews Endocrinology
- Tesofensine, a Novel Triple Monoamine Reuptake Inhibitor, Induces Appetite Suppression by Indirect Stimulation of α1 Adrenoceptor and Dopamine D1 Receptor Pathways in the Diet-Induced Obese Rat
- (2010) Anne Marie D Axel et al. NEUROPSYCHOPHARMACOLOGY
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Functional polymorphism in the GPR55 gene is associated with anorexia nervosa
- (2010) Hiroki Ishiguro et al. SYNAPSE
- Effect of oral immunization with pooled antigens derived from adipose tissue on atherosclerosis and obesity indices
- (2010) Aldar S. Bourinbaiar et al. VACCINE
- Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults
- (2009) Jill A Parnell et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- New central targets for the treatment of obesity
- (2009) Bruce J. Sargent et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of prebiotic fibre supplementation on hepatic gene expression and serum lipids: a dose–response study in JCR:LA-cp rats
- (2009) Jill A. Parnell et al. BRITISH JOURNAL OF NUTRITION
- Loss of GABAergic Signaling by AgRP Neurons to the Parabrachial Nucleus Leads to Starvation
- (2009) Qi Wu et al. CELL
- High Incidence of Metabolically Active Brown Adipose Tissue in Healthy Adult Humans: Effects of Cold Exposure and Adiposity
- (2009) M. Saito et al. DIABETES
- The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies
- (2009) L. Blonde et al. DIABETES OBESITY & METABOLISM
- Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study
- (2009) L. Lind et al. EUROPEAN HEART JOURNAL
- Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet
- (2009) Ivana Dostálová et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
- (2009) P. D. Cani et al. GUT
- Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
- (2009) C M Mack et al. INTERNATIONAL JOURNAL OF OBESITY
- The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity
- (2009) I Akpan et al. INTERNATIONAL JOURNAL OF OBESITY
- The genetic and environmental influences on childhood obesity: a systematic review of twin and adoption studies
- (2009) K Silventoinen et al. INTERNATIONAL JOURNAL OF OBESITY
- Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands
- (2009) Ankur Kapur et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of Genome Size on AAV Vector Packaging
- (2009) Zhijian Wu et al. MOLECULAR THERAPY
- Initiation of myoblast to brown fat switch by a PRDM16–C/EBP-β transcriptional complex
- (2009) Shingo Kajimura et al. NATURE
- Endocannabinoid Signaling Is Required for Development and Critical Period Plasticity of the Whisker Map in Somatosensory Cortex
- (2009) Lu Li et al. NEURON
- Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy
- (2009) Eric Ravussin et al. Obesity
- Is it Time to Change the Way We Report and Discuss Weight Loss?
- (2009) George A. Bray et al. Obesity
- Ghrelin vaccination decreases plasma MCP-1 level in LDLR−/−-mice
- (2009) Eija Kellokoski et al. PEPTIDES
- The β3-adrenoceptor as a therapeutic target: Current perspectives
- (2009) Maria Grazia Ursino et al. PHARMACOLOGICAL RESEARCH
- Acute effect of infection by adipogenic human adenovirus Ad36
- (2008) Magdalena Pasarica et al. ARCHIVES OF VIROLOGY
- Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
- (2008) J. F. List et al. DIABETES CARE
- Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes
- (2008) P. V. Højberg et al. DIABETOLOGIA
- A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release
- (2008) Zhi-Liang Chu et al. ENDOCRINOLOGY
- The GPR55 ligand l-α-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
- (2008) Christopher M. Henstridge et al. FASEB JOURNAL
- Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
- (2008) Arne Astrup et al. LANCET
- PRDM16 controls a brown fat/skeletal muscle switch
- (2008) Patrick Seale et al. NATURE
- Oxytocin receptor-deficient mice developed late-onset obesity
- (2008) Yuki Takayanagi et al. NEUROREPORT
- Weight Loss Produced by Tesofensine in Patients With Parkinson's or Alzheimer's Disease
- (2008) Arne Astrup et al. Obesity
- Central and Peripheral Regulation of Food Intake and Physical Activity: Pathways and Genes
- (2008) Natalie R. Lenard et al. Obesity
- The Brain, Appetite, and Obesity
- (2007) Hans-Rudolf Berthoud et al. Annual Review of Psychology
- Novel cannabinoid receptors
- (2007) A J Brown BRITISH JOURNAL OF PHARMACOLOGY
- GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity
- (2007) H A Overton et al. BRITISH JOURNAL OF PHARMACOLOGY
- The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
- (2007) D G Johns et al. BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties
- (2007) Jack Bergman et al. PHYSIOLOGY & BEHAVIOR
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started